On Tuesday, Wells Fargo (WFC) reported fourth-quarter earnings of $1 per share. That beat Wall Street�� consensus by two cents per share. Strangely, the shares initially dropped after the earnings report (yep, we know how melodramatic traders can be).
Then on Wednesday, it was as if rationality and math suddenly dawned on everyone, and the nervous traders got squeezed out. Before the closing bell, WFC had rallied to a new 52-week high.
Lesson: Don�� trust the market�� first reaction. Actually, keep a wary eye on the second and third ones as well.
Now that I��e had a chance to look at the earnings from Wells, I can say that I�� impressed. Net income for Q4 rose 10% over last year�� Q4. For the entire year, Wells�� net income rose 16% to $21.9 billion. This was their fifth straight record year. Last year, Wells made more money than JPMorgan (JPM) (sorry, Jamie).
Top Electric Utility Companies To Watch In Right Now: AmerisourceBergen Corp (ABC)
AmerisourceBergen Corporation (AmerisourceBergen), incorporated on March 16, 2001, is a pharmaceutical services companies serving the United States, Canada, and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. The Company distributes a range of pharmaceuticals (including specialty pharmaceutical products), generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. In addition, the Company furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmacy automation, inventories management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. The Company serves its customers (healthcare providers, pharmaceutical manufacturers, and specialty drug patients) through a network of distribution service centers and other operations in the United States, Canada, and global markets. In the Company's pharmaceutical distribution business, the Company is a source of supply of pharmaceutical and related products to its healthcare provider customers.
As of September 30, 2012, the Company's operations were comprised of the Pharmaceutical Distribution reportable segment and Other. Other consists of the AmerisourceBergen Consulting Services (ABCS) and World Courier operating segments. In September 2011, the Company acquired IntrinsiQ, LLC (IntrinsiQ) and Premier Source! . IntrinsiQ is a provider of informatics solutions, which help community oncologists make treatment decisions for their patients. Premier Source is a provider of consulting and reimbursement services to medical device, pharmaceutical, molecular diagnostic, and biotechnology manufacturers, as well as other health services companies. On November 1, 2011, the Company acquired TheraCom, LLC (TheraCom). TheraCom is a provider of commercialization support services to the biotechnology and pharmaceutical industry, including reimbursement and patient access support services. On April 30, 2012, the Company acquired World Courier Group, Inc. (World Courier), which is a global specialty transportation and logistics provider for the biopharmaceutical industry.
Pharmaceutical Distribution Segment
The Pharmaceutical Distribution reportable segment is consisted of two operating segments, which include the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG). Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. ABDC distributes a offering of brand-name pharmaceuticals (including specialty pharmaceutical products) and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. ABDC also provides pharmacy management, staffing and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets, and supply management software to a range of retail and institutional healthcare providers. In addition, ABDC delivers packaging solutions to institutional and retail healthcare providers.!
ABSG, through a range of operating businesses, provides pharmaceutical distribution and other services to physicians who specialize in a range of disease states, especially oncology, and to other healthcare providers, including dialysis clinics. ABSG also distributes plasma and other blood products, injectible pharmaceuticals and vaccines. In addition, ABSG provides third party logistics and other services for biotechnology and other pharmaceutical manufacturers. The Company's use of the term specialty and specialty pharmaceutical products refers to drugs used to treat complex diseases, such as cancer, diabetes, and multiple sclerosis. Specialty pharmaceutical products are part of complex treatment regimens for serious conditions and diseases, which require ongoing clinical monitoring.
Other
ABCS, through a number of operating businesses, provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and copay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers. World Courier, which operates in over 50 countries, is a specialty transportation and logistics provider for the biopharmaceutical industry. As of September 30, 2012, the Company committed to a plan to divest AndersonBrecon.
The Company competes with Cardinal Health, Inc., McKesson Corporation, FFF Enterprises, Henry Schein, Inc. and UPS Logistics.
Advisors' Opinion:- [By Dividends4Life]
Memberships and Peers: CAH is a member of the S&P 500, a Dividend Aristocrat and a member of the Broad Dividend Achievers��Index. The company's peer group includes: AmerisourceBergen Corporation (ABC) with a 1.3% yield, McKesson Corporation (MCK) with a 0.6% yield and Owens & Minor Inc. (OMI) with a 2.5% yield.
Top 10 Diversified Bank Companies To Buy For 2014: Targacept Inc.(TRGT)
Targacept, Inc., a biopharmaceutical company, engages in the discovery, design, and development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of diseases and disorders of the nervous system. Its products include TC-5214, a nicotinic channel modulator, which is in Phase III clinical trials as an adjunct treatment for depressive disorder; and in Phase IIb clinical trial for switch monotherapy in patients with depressive disorder. The company?s small molecule products include TC-5619, which is under two separate Phase II clinical trials to treat negative symptoms and cognitive dysfunction in schizophrenia, inattentive-predominant attention deficit/hyperactivity disorder, and Alzheimer?s disease; AZD3480, a product under Phase IIb clinical trials for the treatment of mild to moderate Alzheimer?s disease; AZD1446 for treatment of Alzheimer?s disease; TC-6987 under Phase II clinical trials to treat asthma and type 2 diabetes; and TC-6499 for the treatm ent for gastrointestinal disorders. It has a collaborative research and license agreement with AstraZeneca AB for the development and commercialization of AZD3480, TC-5214, and TC-5619; and a product development and commercialization agreement with SmithKline Beecham Corporation and Glaxo Group Limited to discover, develop, and market product candidates that selectively target specified NNR subtypes in specified therapeutic focus areas. Targacept, Inc. was founded in 1997 and is based in Winston-Salem, North Carolina.
Advisors' Opinion:- [By Lauren Pollock]
Targacept Inc.'s(TRGT) investigational secondary treatment for schizophrenia didn’t show significant improvement in negative symptoms or cognitive function in a Phase 2b trial after 24 weeks. The biopharmaceutical company said it wouldn’t pursue further development of the therapy for the mental illness or for Alzheimer’s Disease. Shares fell 31% to $4.09 premarket.
- [By DailyFinance Staff]
Investors took a wait-and-see attitude Tuesday, but airline stocks lost altitude. The market is in a holding pattern until 2 p.m. Wednesday, when the Fed reveals details of this week's FOMC policy meetings, and whether it's ready to begin cutting back on its main economic stimulus program. If it does begin to taper, the next debate will begin immediately: Is that good or bad for investors? On Wall Street today, the Dow Jones industrial average (^DJI) edged down 9 points, the Nasdaq composite (^IXIC) fell nearly 6, and the Standard & Poor's 500 index (^GPSC) lost 5 points. The Dow's gainers were led by a pair of companies hiking their dividends. 3M (MMM), which makes everything from Post-It notes to medical equipment, rose 3 percent after increasing its payout by 35 percent. And Boeing (BA) rose 1 percent. It boosted the dividend by 50 percent and announced a big stock buyback. The other big blue chip winner was Visa (V), which gained another 2.5 percent. Its stock is now up 43 percent from a year ago. On the downside, Verizon (VZ), IBM (IBM), McDonald's (MCD) and Microsoft (MSFT) all lost about one percent. Microsoft says it will not name a new CEO until next year. And airline stocks were broadly lower. United (UAL) and Delta (DAL) both fell 3 percent. American Airlines (AAL), which completed its merger with U.S. Airways last week, fell 2 percent. And Southwest (V) also lost 2 percent. Brokerage recommendations gave a boost to several issues. Data storage companies Seagate (STX), up 3 percent, and Western Digital (WDC), up 2.5 percent, following JP Morgan upgrades. And iRobot (IRBT) surged 17 percent after Raymond James gave it a 'strong buy.' Shares of Facebook (FB) rose 2 percent, hitting an all-time high. The social media giant is rolling out new video ads this week. That's expected to boost revenue. The question is, will it alienate users? On the downside, Targacept (TRGT) lost more than a third of its value. A clinical trial of its schizophreni
Top 10 Diversified Bank Companies To Buy For 2014: PhotoMedex Inc.(PHMD)
PhotoMedex, Inc., together with its subsidiaries, operates as a skin health company in North America and internationally. It offers disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company provides no!no! hair removal products; professional products, including capital equipment to physicians and skin care specialists; XTRAC laser products for the treatment of psoriasis and vitiligo; NEOVA formulations for premature skin aging due to UV-induced DNA damage; Omnilux Light-emitting diode (LED) systems to treat wrinkles, acne, minor muscle pain, and pigmented lesions; Lumi�e light therapy equipment, a non-invasive skin care solution for use in non-medical applications primarily salons and spas; and topical lotions to improve the appearance of fine lines, wrinkles, skin tone, and blemishes. It also provides home-use devices under the no!no! brand for various indications, including hair removal, acne treatment, and ski n rejuvenation; and a professional product line for acne clearance, skin tightening, psoriasis care, and hair removal to physician clinics and spas. In addition, the company engages in the development, manufacture, and sale of surgical products, including proprietary free-beam and Contact Laser Systems for surgery. Further, it sells surgical disposables and accessories to hospitals and surgery centers; and repairs, maintains, and provides replacement parts for the company?s products. The company is headquartered in Montgomeryville, Pennsylvania.
Advisors' Opinion:- [By John Udovich]
Large cap serial acquirer�Valeant Pharmaceuticals International Inc (NYSE: VRX) is teaming up with activist investor�Bill Ackman to pursue large cap Botox maker Allergan, Inc (NYSE: AGN), but stocks like Cutera, Inc (NASDAQ: CUTR), Cynosure, Inc (NASDAQ: CYNO), PhotoMedex Inc (NASDAQ: PHMD) and Syneron Medical Ltd (NASDAQ: ELOS)�actually offer investors more exposure to the growing anti aging and aesthetics market (Note: See my recent article: These Small Caps Seek to Treat Your Crow�� Feet and Double Chin (RVNC & KYTH)). To begin with, Valeant Pharmaceuticals International has a wide focus on neurology, dermatology and infectious diseases�but acquiring the maker of Botox won�� be its first foray into the aesthetic market�because earlier this year, the company completed its acquisition of Solta Medical Inc (NASDAQ: SLTM) -�a designer, developer, manufacturer and marketer of�energy-based medical device systems for aesthetic applications.�And while�Allergan, Inc may be most well known for Botox, its actually a pretty big�company focused on a diverse range of areas, including ophthalmic pharmaceuticals, dermatology, neuroscience, urology and cosmetics���meaning the following stocks offer investors better exposure to the aesthetics market:
- [By Lauren Pollock]
Skin-health company PhotoMedex Inc.(PHMD) issued a dour third-quarter report as it didn’t log any consumer sales to its Japanese distributor, which changed its business model and affected other companies besides PhotoMedex. Unless it generates revenue from Japan, the company’s current-quarter sales are poised to fall short of consensus views. Shares dropped 10% to $11.47 premarket.
Top 10 Diversified Bank Companies To Buy For 2014: Northland Power Inc (NPIFF.PK)
Northland Power Inc. (Northland) owns or has an economic interests, through its subsidiaries, in operating power-producing facilities and a pipeline of construction and development projects. Its operating assets consist of facilities, which produce electricity from natural gas and renewable sources. Its subsidiaries include Iroquois Falls Corp., which owns the Iroquois Falls Facility; Kingston LP, which owns the Kingston Facility; Thorold LP, which owns the Thorold Facility; Mont Miller LP; Jardin LP, which owns the Jardin wind farm; DK Windpark Kavelstorf GmbH & Co. KG and DK Burgerwindpark Eckolstadt GmbH & Co. KG, which own the German Wind Farms; Mont Louis LP, which owns the Mont Louis Wind Farm; Spy Hill LP, which owns the Spy Hill Facility, and North Battleford LP, which owns the North Battleford Facility. Northland owns a 19% interest in Panda Energy Corporation, which through its wholly owned subsidiaries owns the 230 mega-watts combined-cycle Panda-Brandywine facility. Advisors' Opinion:- [By Markus Aarnio]
Emera's competitors include Northland Power (NPIFF.PK), Fortis (FRTSF.PK), and Atlantic Power (AT). Northland Power has seen insider buying in August and has a dividend yield of 7.6%. Fortis has seen both insider buying and insider selling in August. Fortis has a dividend yield of 4.1%. Atlantic Power saw insider buying last time in April. Atlantic Power has a dividend yield of 9.4%.
Top 10 Diversified Bank Companies To Buy For 2014: Mobile TeleSystems (MBT)
Mobile TeleSystems OJSC, together with its subsidiaries, provides telecommunications services primarily in the Russian Federation, Ukraine, Uzbekistan, Armenia, and Belarus. The company provides a range of mobile and fixed line voice and data telecommunications services, including transmission, broadband, pay-TV, and various value-added services; and sells equipment and accessories. It also offers network access services, including mobile cellular voice and data communication services; automatic roaming services; GPRS and Internet access services; and 3G technology. In addition, the company�s services include the design, construction, and installation of local voice and data networks capable of interconnecting with fixed line operators; installation and maintenance of cellular payphones; lease of digital communication channels; and provision of access to open computer databases and data networks, including the Internet, as well as video conferencing, and fixed, local, and long-distance telecommunications services. Its value-added services comprise call divert/forwarding, caller ID and anti-caller ID display, conference calling, WiFi, GPRS, intelligent call assistant, APN remote access point, fixed mobile convergence, enhanced data rates for GSM Evolution, call barring, SMS, mobile office, voicemail, mobile banking, wireless application protocol, MTS-Connect, SIM-browser, point-to-point transfer, unstructured supplementary services data, downlink packet access, mobile TV, call waiting, MMS, ring tones, missed call alert, itemization of monthly bills, information and directory, international access, WEB and WAP portal, customer care system, ring back tone, collect call, and location-based services. As of December 31, 2011, the company had a mobile subscriber base of approximately 101.14 million. It has a strategic partnership with Vodafone. The company was founded in 1993 and is headquartered in Moscow, the Russian Federation.
Advisors' Opinion:- [By MONEYMORNING.COM]
For one thing, Russian telecom firms VimpelCom Ltd. (Nasdaq ADR: VIP) and Mobile TeleSystems OJSC (NYSE ADR: MBT) each do "considerable business" in Ukraine, the trade journal reports. For instance, MTS had about 22.4 million subscribers in that country as of September, making it Ukraine's No. 2 mobile provider, Reuters reported. And VimpelCom gets about 8% of its cash flow from that market.
- [By MONEYMORNING.COM]
With that in mind, the four main Russian tech leaders investors should know about are:
VimpelCom Ltd. (ADR) (Nasdaq: VIP), a broad telecom play. The company provides both fixed and wireless web access, as well as mobile communications and services. The company has a number of subsidiaries that, taken together, have something like 215 million subscribers. Mobile Telesystems OJSC (ADR) (NYSE: MBT), a straight-up mobile play that operates in the Russian Federation, Ukraine, Uzbekistan, Turkmenistan, and Armenia. Plus, it has a strategic relationship with one of Europe's major players, Vodafone Group Plc (ADR) (Nasdaq: VOD). Qiwi PLC (Nasdaq: QIWI), a leader in electronic payments through kiosks, the web, and mobile platforms. It's Russia's version of PayPal - so we better not tell Carl Icahn... he might start a campaign to break up that company, too. And Yandex NV (Nasdaq: YNDX), which is the "Google of Russia." Yandex operates the world's fourth-ranked search engine and enjoys a 60% market share in its home country. Google, with about a quarter of the market, is a very distant second there.That's a great rundown on Russia's tech leaders. Are there any worth buying at this level? And why?
- [By Jake L'Ecuyer]
Telecommunications services sector was the leading decliner in the US market today. Telecommunications services stocks dropped 0.43% in today's trading. Among the stocks, Mobile Telesystems OJSC (NYSE: MBT) was down more than 4.8%, while Telecom Argentina SA (NYSE: TEO) tumbled around 2.5%.
Top 10 Diversified Bank Companies To Buy For 2014: Corcept Therapeutics Incorporated(CORT)
Corcept Therapeutics Incorporated, a development stage pharmaceutical company, engages in the discovery and development of drugs for the treatment of severe metabolic and psychiatric disorders. The company focuses on the development of drugs for disorders that are associated with steroid hormone called cortisol. Corcept Therapeutics Incorporated has completed its Phase III study of CORLUX for the treatment of Cushing's Syndrome, as well as has an ongoing Phase III study of CORLUX for the treatment of the psychotic features of psychotic depression; and a Phase II program for CORT 108297 and an IND-enabling program for CORT 113083. It has a patent license from Stanford University for the use of GR-II antagonists, as well as agreements with ICON Clinical Research, LP; and MedAvante, Inc. The company was founded in 1998 and is based in Menlo Park, California.
Advisors' Opinion:- [By James E. Brumley]
Looks out Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), you're on notice too. Corcept Therapeutics Incorporated (NASDAQ:CORT) is nipping at your heels, and better still, shares of the company looks like they're about to dole out a sizeable reward to investors who see the writing on the wall.
Top 10 Diversified Bank Companies To Buy For 2014: Ishares S&P 500 (IVV)
iShares Core S&P 500 ETF, formerly iShares S&P 500 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of United States large-cap stocks, as represented by the Standard & Poor�� 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market. The Index serves as the underlying index for the S&P 500/Citigroup Growth and Value Index series.
The Index is a capitalization-weighted index from a range of industries chosen for market size, liquidity and industry group representation. The component stocks are weighted according to the total float-adjusted market value of their outstanding shares. The Index is adjusted to reflect changes in capitalization resulting from mergers, acquisitions, stock rights, substitutions and other capital events. The Fund�� investment advisor is Barclays Global Fund Advisor.
Advisors' Opinion:- [By Victor Selva]
ETFs require no investment minimum beyond the price of one share. iShares Core S&P 500 (IVV) charges 0.07%, while the largest S&P 500 Index fund, SPDR S&P 500 (SPY), charges 0.09%. Vanguard S&P 500 ETF (VOO) charges 0.05% and is technically a separate share class of the Vanguard 500 Index mutual fund.
- [By Dan Caplinger]
Much smaller is the iShares Core S&P 500 ETF (NYSEMKT: IVV ) . With about $43 billion under management, the iShares ETF comes with lower expenses of 0.07%, but much lower average daily volume of just 3.8 million shares. Like the Spiders, its share price roughly corresponds to a tenth of the value of the S&P 500 index.
- [By John Udovich]
One of the most famous scenes in the cult classic, the Graduate, was when Mr. McGuire�took Dustin Hoffman�� character aside and said�"Ben, I want to say one word to you, just one word: Plastics"; but what about the Berry Plastics Group Inc (NYSE: BERY) and its performance verses that of the�iShares S&P 500 Index ETF (NYSEARCA: IVV), iShares Russell Midcap Index Fund ETF (NYSEARCA: IWR) and iShares S&P SmallCap 600 Index ETF (NYSEARCA: IJR)? I should mention that plastics and the Berry Plastics Group was not the place to be yesterday as the stock took a tumble on reduced guidance.
No comments:
Post a Comment